- Home
- BWB vs ETON Comparison
BWB vs ETON Comparison
Compare BWB & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWB
- ETON
- Stock Information
- Founded
- BWB 2005
- ETON 2017
- Country
- BWB United States
- ETON United States
- Employees
- BWB N/A
- ETON N/A
- Industry
- BWB Major Banks
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- BWB Finance
- ETON Health Care
- Exchange
- BWB Nasdaq
- ETON Nasdaq
- Market Cap
- BWB 365.0M
- ETON 329.8M
- IPO Year
- BWB 2018
- ETON 2018
- Fundamental
- Price
- BWB $14.52
- ETON $18.33
- Analyst Decision
- BWB Strong Buy
- ETON Strong Buy
- Analyst Count
- BWB 2
- ETON 3
- Target Price
- BWB $17.50
- ETON $24.00
- AVG Volume (30 Days)
- BWB 58.1K
- ETON 340.5K
- Earning Date
- BWB 01-29-2025
- ETON 03-13-2025
- Dividend Yield
- BWB N/A
- ETON N/A
- EPS Growth
- BWB N/A
- ETON N/A
- EPS
- BWB 1.03
- ETON N/A
- Revenue
- BWB $106,036,000.00
- ETON $34,677,000.00
- Revenue This Year
- BWB N/A
- ETON $22.27
- Revenue Next Year
- BWB $11.90
- ETON $80.01
- P/E Ratio
- BWB $13.83
- ETON N/A
- Revenue Growth
- BWB N/A
- ETON 5.64
- 52 Week Low
- BWB $10.52
- ETON $3.03
- 52 Week High
- BWB $16.00
- ETON $18.41
- Technical
- Relative Strength Index (RSI)
- BWB 57.69
- ETON 61.65
- Support Level
- BWB $13.70
- ETON $16.02
- Resistance Level
- BWB $14.74
- ETON $17.80
- Average True Range (ATR)
- BWB 0.42
- ETON 1.02
- MACD
- BWB 0.14
- ETON 0.16
- Stochastic Oscillator
- BWB 69.64
- ETON 76.01
About BWB Bridgewater Bancshares Inc.
Bridgewater Bancshares Inc offers retail and commercial loan and deposit services to customers within the Minneapolis-St. Paul-Bloomington, MN-WI Metropolitan Statistical Area. The company engages in providing a wide range of deposit and lending products. Its products and services include commercial deposits, loans, online business services, credit card, mobile banking, and remote deposit services.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.